Cytodyn Inc (CYDY)

[LifeLongLearner]

3X,

At least a portion of my intel comes from having a friend in the cancer trial. In that example Dr. Jay has been trying to get the FDA to increase the dosage for close to a year. The FDA has continued to say NO in spite of no side affects. One has to wonder why they would refuse the request of the medical team running the trial.

The dosage issue is similar to the constraint they put on CD12. As a result we saw the mortality reduction of 82% at 14 days tapper off to 24% (still better than any approved drug) at 28 days. You then add the DSMC recommendation to not change the primary end point and suggested looking at 42 day mortality (with no change in dosage), it feels like they were trying to make the trial fail.

Also, look at the hospital LOS of CD12. It blows all of the other drugs away. So, just because LOS was not selected as a primary end point, we can’t approve a drug that is clearly superior to the current standard of care?

I could go on but you know the story as well as I do.

Just as an aside, I also live in the Vancouver area (I think you do as well). My guess is there is a good chance we know each other or at a minimum share common friends.

Thanks for helping CYDY get this far by being an early supporter.

LLL